Nurix Therapeutics's total assets for Q1 2026 were $636.13M, a decrease of -7.56% from the previous quarter. NRIX total liabilities were $155.24M for the fiscal quarter, a 3.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.